Robert Harrington to Cell- and Tissue-Based Therapy
This is a "connection" page, showing publications Robert Harrington has written about Cell- and Tissue-Based Therapy.
Connection Strength
0.187
-
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study. Cell Transplant. 2016; 25(9):1701-1711.
Score: 0.130
-
Myocardial ischemia and infarction. J Am Coll Cardiol. 2004 Jul 21; 44(2 Suppl A):10A-12A.
Score: 0.057